Kennedy and MAHA say they aren’t anti-vaccine. They can prove it by promoting the MMR vaccine, writes Brinda Adhikari.
The FDA said it had rejected a cell therapy intended for patients with Duchenne muscular dystrophy developed by Capricor ...
A graduate student who is a scientific researcher at Princeton was detained by ICE while traveling home after presenting ...
Sanofi weighs an Insmed takeover, the FDA slams J&J over misleading bladder cancer drug claims, and more pharma news: ...
Medicare does not cover many of the lifestyle interventions that could keep people from getting sick in the first place.
STAT reporters preview JPM 2027, sharing the trends, companies, rumors, and stories to watch at the J.P. Morgan Healthcare ...
Tax filings show the MAHA Institute spent more than $1 million in 2025, ending its first year with just $171,000 as events ...
Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of ...
Matthew Herper covers medical innovation — both its promise and its perils. Executives at Epic Systems Corp., the largest maker of electronic health records, said Wednesday they would make it easier ...
Sen. Bernie Sanders pushed back on assumptions that Trump would veto an expanded Medicare plan. “I am not absolutely certain ...
A monoclonal antibody holds promise in preventing malaria, but researchers found it interfered with a new vaccine when used ...